QT
CTSO icon

Quantbot Technologies’s Cytosorbents Corp CTSO Stock Holding History

Quantbot Technologies’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,200
Closed -$34K – 1577
2021
Q3 		$34K Buy
4,200
+3,600
+600% +$29.2K ﹤0.01% 1173
2021
Q2 		$4K Buy
+600
New +$5.06K ﹤0.01% 1376
2020
Q3 		– Sell
-1,219
Closed -$12K – 1346
2020
Q2 		$12K Buy
+1,219
New +$11.2K ﹤0.01% 896

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's CTSO Position: Q4 2021 in Review

Quantbot Technologies sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 4,200 shares — an estimated $34K sold.

Quantbot Technologies first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $34K in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • Quantbot Technologies reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 4,200 Cytosorbents Corp shares in Q4 2021, an estimated $34K.
  • Quantbot Technologies first reported a position in Cytosorbents Corp in Q2 2020 and held it in 3 quarters.
  • Quantbot Technologies's Cytosorbents Corp position peaked at $34K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.